Dr. Goldman on the Use of Immunotherapy in Oncogene-Driven NSCLC
LATEST
- Medicine Branch (A-M) / Hematology
Dr. Goldman on the Use of Immunotherapy in Oncogene-Driven NSCLC
[embedded content]Jonathan W. Goldman, MD, health sciences clinical instructor, Department of Medicine, and Hematology/Oncology member, Jonsson Comprehensive Cancer Center Signal Transduction and Therapeutics Program, UCLA, discusses the use of immun